Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,321 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Completed

A Study of the Long-Term Outcomes of HIV-Positive Patients

NCT00000932

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
Locations
  • Dr. M. Estes Med. Practice CRS Mill Valley, California, United States
  • Dr. Robert Scott Med. Practice CRS Oakland, California, United States
  • East Bay AIDS Ctr. CRS Oakland, California, United States
  • Dr. Shawn Hassler Med. Practice CRS San Francisco, California, United States
View all 91 locations
View Trial Details
Completed

Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding

NCT00640263

Conditions
Behavior, Blood-Borne Infections, Breast Feeding, +14 more
Locations
  • Université de Ouagadougou Ouagadougou, Burkina Faso
  • East London Hospital Complex East London, South Africa
  • Dept of Paediatrics and Child Health, Makerere University Kampala, Uganda
  • Dept of Paediatrics and Child Health, School of Medicine, University of Zambia Lusaka, Zambia
View Trial Details
Completed

Examining Factors That May Influence Resistance to HIV-1 Infection

NCT00351442

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Uganda Virus Research Institute, MRC/UVRI Uganda Research Unit on AIDS CHAVI CRS Entebbe, Uganda
  • King's College Hosp., Caldecot Ctr. CHAVI CRS London, United Kingdom
  • St. Mary's Hosp. of London, Imperial College School of Medicine, Clinical Trials Ctr. CHAVI CRS London, United Kingdom
View Trial Details
Completed

VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients

NCT00561925

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1100.1486.0040 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1100.1486.0013 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 1100.1486.0017 Boehringer Ingelheim Investigational Site Bakersfield, California, United States
  • 1100.1486.0001 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
View all 202 locations
View Trial Details
Completed

Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.

NCT00531206

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Aachen, Germany
  • Boehringer Ingelheim Investigational Site Berlin, Germany
  • Boehringer Ingelheim Investigational Site Bremen, Germany
  • Boehringer Ingelheim Investigational Site Cologne, Germany
View all 27 locations
View Trial Details

Related conditions